p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
about
p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@ast
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@en
type
label
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@ast
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@en
prefLabel
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@ast
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells.
@en
P2093
P2860
P356
P1433
P1476
p62/SQSTM1 as an oncotarget me ...... in human ovarian cancer cells
@en
P2093
Juan-Juan Zhang
Li-Chao Zhang
Lian-Kun Sun
Sheng-Yao Lu
Ya-Nan Liu
Ya-Nan Xue
P2860
P304
P356
10.1111/CAS.13276
P50
P577
2017-06-25T00:00:00Z